Universidade Federal de Alfenas, Programa de Pós-Graduação em Enfermagem, Alfenas, MG, Brasil.
Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, Programa de Pós-Graduação em Enfermagem, Ribeirão Preto, SP, Brasil.
Rev Esc Enferm USP. 2020 Oct 12;54:e03624. doi: 10.1590/S1980-220X2019005403624. eCollection 2020.
To evaluate the effect of operative groups on teaching self-care for diabetic foot prevention.
Controlled, blinded clinical trial with volunteers presenting type 2 Diabetes Mellitus, randomized into treatment (55 subjects) and control (54 subjects) groups. The treatment group received the educational intervention "Teaching foot self-care", whereas the control group was simply evaluated. Feet evaluation was conducted before and after the intervention, as well as 15 days later in a follow-up. The intervention was conducted through an operative group and developed with orientation via writing, explained through dialogue and role-playing. The following tests were used: Shapiro-Wilk, Chi-squared, t-test, Mann-Whitney, McNemar, and paired Wilcoxon.
One-hundred and nine volunteers took part in this study. Their sociodemographic variables were homogeneous. In an analysis between groups, an improvement was observed after the educational intervention regarding most variables related to skin annexes, blood flow, foot sensitivity, and foot pressure. Improved scores for risk of diabetic foot in the treatment group were observed.
The educational intervention through operative group was efficient, for it encouraged self-care and reduced potential risk of diabetic foot. Brazilian Registry of Clinical Trials (Registro Brasileiro de Ensaios Clínicos): RBR- 753 Kcg.
评估手术组在糖尿病足预防自我护理教学中的效果。
采用志愿者 2 型糖尿病对照、盲法临床试验，随机分为治疗（55 例）和对照组（54 例）。治疗组接受“足部自我护理教育”的教育干预，而对照组仅进行评估。在干预前后以及 15 天后的随访中对足部进行评估。干预通过手术组进行，并通过书面指导、对话和角色扮演进行指导。使用了 Shapiro-Wilk、卡方、t 检验、Mann-Whitney、McNemar 和配对 Wilcoxon 检验。
共有 119 名志愿者参与了这项研究。他们的社会人口统计学变量是同质的。在组间分析中，教育干预后，与皮肤附件、血流、足部敏感性和足部压力相关的大多数变量均有所改善。治疗组糖尿病足风险的评分有所提高。
通过手术组进行的教育干预是有效的，因为它鼓励自我护理并降低了糖尿病足的潜在风险。巴西临床试验注册（巴西临床试验注册）：RBR-753Kcg。
